NasdaqGS - Nasdaq Real Time Price USD

Indivior PLC (INDV)

Compare
11.99
+0.06
+(0.50%)
At close: January 24 at 4:00:01 PM EST
12.13
+0.14
+(1.17%)
Pre-Market: 7:52:13 AM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,182,000.00
1,093,000.00
901,000.00
791,000.00
647,000.00
Cost of Revenue
259,000.00
186,000.00
159,000.00
127,000.00
97,000.00
Gross Profit
923,000.00
907,000.00
742,000.00
664,000.00
550,000.00
Operating Expense
930,000.00
915,000.00
833,000.00
483,000.00
706,000.00
Operating Income
-7,000.00
-8,000.00
-91,000.00
181,000.00
-156,000.00
Net Non Operating Interest Income Expense
-9,000.00
5,000.00
-10,000.00
-23,000.00
-17,000.00
Pretax Income
-12,000.00
1,000.00
-95,000.00
190,000.00
-173,000.00
Tax Provision
-9,000.00
-1,000.00
-42,000.00
-15,000.00
-25,000.00
Net Income Common Stockholders
-3,000.00
2,000.00
-53,000.00
205,000.00
-148,000.00
Diluted NI Available to Com Stockholders
-3,000.00
2,000.00
-53,000.00
205,000.00
-148,000.00
Basic EPS
-0.03
0.01
-0.38
1.40
-1.00
Diluted EPS
-0.03
0.01
-0.38
1.35
-1.00
Basic Average Shares
134,998.25
137,306.00
139,012.00
145,659.80
146,572.60
Diluted Average Shares
136,931.00
141,800.00
145,617.00
154,228.20
153,999.00
Total Operating Income as Reported
-3,000.00
-4,000.00
-85,000.00
213,000.00
-156,000.00
Total Expenses
1,189,000.00
1,101,000.00
992,000.00
610,000.00
803,000.00
Net Income from Continuing & Discontinued Operation
-3,000.00
2,000.00
-53,000.00
205,000.00
-148,000.00
Normalized Income
-6,160.00
-1,160.00
-57,740.00
181,640.00
-148,000.00
Interest Income
27,000.00
43,000.00
18,000.00
1,000.00
7,000.00
Interest Expense
36,000.00
37,000.00
29,000.00
26,000.00
24,000.00
Net Interest Income
-9,000.00
5,000.00
-10,000.00
-23,000.00
-17,000.00
EBIT
24,000.00
38,000.00
-66,000.00
216,000.00
-149,000.00
EBITDA
57,000.00
66,000.00
-45,000.00
238,000.00
-123,000.00
Reconciled Cost of Revenue
259,000.00
186,000.00
159,000.00
127,000.00
97,000.00
Reconciled Depreciation
33,000.00
28,000.00
21,000.00
22,000.00
26,000.00
Net Income from Continuing Operation Net Minority Interest
-3,000.00
2,000.00
-53,000.00
205,000.00
-148,000.00
Total Unusual Items Excluding Goodwill
4,000.00
4,000.00
6,000.00
32,000.00
--
Total Unusual Items
4,000.00
4,000.00
6,000.00
32,000.00
--
Normalized EBITDA
53,000.00
62,000.00
-51,000.00
206,000.00
-123,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
840.00
840.00
1,260.00
8,640.00
--
12/31/2020 - 12/29/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IRWD Ironwood Pharmaceuticals, Inc.
3.7100
-1.59%
 
6785.TWO Alar Pharmaceuticals Inc.
126.00
+0.40%
 
PCRX Pacira BioSciences, Inc.
24.52
+5.10%
 
526075.BO 526075.BO,0P0000BXCE,0
4.5000
0.00%
 
LFCR Lifecore Biomedical, Inc.
6.32
+2.93%
 
6CQ.BE Cresco Labs Inc
0.8930
+1.13%
 
R9U2.F Green Thumb Industries Inc.
6.84
+2.63%
 
AX9.SG Akebia Therapeutics Inc
2.1460
-4.96%
 
HKMPF Hikma Pharmaceuticals PLC
26.64
0.00%
 
BON.SG Boiron SA
25.35
+0.60%